Back to top
Close
Steve Reitmeister

My Free Gift to You: Zacks' 7 Best Stocks for the Next 30 Days

Dear Zacks.com Visitor,

I am delighted to give you seven stocks hand-picked by our experts from today's 220 Zacks Rank #1 Strong Buys. Since 1988, this list has nearly tripled the market with an independently verified average gain of +26% per year.

Our 7 Best report reveals the companies expected to jump in price the soonest.

Actavis Plc: (ACT)

(Market Close from NYSE) As of Dec 19, 2014 04:12 PM ET

 Add to portfolio

 ZacksTrade Now

$265.39 USD

265.39
3,526,396

+1.64 (0.62%)

Volume: 3,526,396

Zacks Rank : 2-Buy [?]   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Quote Overview

Stock Activity

Open 263.75
Day Low 261.79
Day High 267.61
52 Wk Low 158.57
52 Wk High 272.75
Avg. Volume 2,639,902
Market Cap 69.91 B
Dividend 0.00 ( 0.00%)
Beta 0.31

Key Earnings Data

Forward PE 19.43
PEG Ratio 1.06
Current Qtr Est 3.49
Current Yr Est 13.57
Most Accurate Est 3.47
Qtr Earnings ESP[?] -0.57%
Exp Earnings Date 2/19/15
Prior Year EPS 13.27
Exp EPS Growth 18.40%
Industry MED-GENERIC DRG

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for ACT

Zacks Rank [?] Rank Change Trend Buy 2
Zacks Industry Rank 51 / 265 (Top 19%)
Equity Research Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
ACTAVIS PLC ACT
AKORN INC AKRX
MYLAN INC MYL
AMPHASTAR PHARM AMPH
AXOGEN CORP AXGN
EVOKE PHARMA EVOK
IMPAX LABORATRS IPXL
KALOBIOS PHARMA KBIO
PROGENICS PHARM PGNX
SUPERNUS PHARMA SUPN

See all MED-GENERIC DRG Peers>>